Empirical Antibiotics for Suspected Bacterial Sepsis in High-Grade NHL Patients

Initial Antibiotic Selection

The American College of Critical Care Medicine recommends administering IV antimicrobials within the first hour of sepsis recognition to reduce mortality in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 1, 2
The Intensive Care Medicine society suggests obtaining appropriate microbiological cultures, including at least two sets of blood cultures, before starting antibiotics if no substantial delay occurs in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 1
The Critical Care Medicine society recommends using broad-spectrum antibiotics that cover all likely pathogens, including bacterial, fungal, and viral agents as appropriate, for patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 2

The Intensive Care Medicine and Critical Care Medicine societies strongly recommend combination therapy with an extended-spectrum beta-lactam plus either an aminoglycoside or a fluoroquinolone for neutropenic NHL patients with sepsis 1, 2
The Critical Care Medicine society suggests combination therapy with an extended-spectrum beta-lactam plus either an aminoglycoside or a fluoroquinolone for non-neutropenic NHL patients with septic shock 2
The Critical Care Medicine society recommends considering beta-lactam plus macrolide for suspected Streptococcus pneumoniae bacteremia in patients with high-grade non-Hodgkin's lymphoma 2

The Intensive Care Medicine and Critical Care Medicine societies recommend reassessing antimicrobial regimen daily for potential de-escalation in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 1, 2
The Critical Care Medicine society recommends that empiric combination therapy should not be administered for more than 3-5 days in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 2
The Critical Care Medicine society suggests de-escalating to the most appropriate single therapy once susceptibility profile is known in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 2
The Intensive Care Medicine society recommends a typical duration of 7-10 days, but longer courses may be needed for slow clinical response, undrainable infection foci, Staphylococcus aureus bacteremia, certain fungal/viral infections, or immunologic deficiencies, including neutropenia 1, 3

The Intensive Care Medicine society recommends tailoring antibiotics to the likely source of infection (respiratory, catheter-related, etc.) in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 1

The Intensive Care Medicine society recommends using biomarkers like procalcitonin to guide discontinuation of empiric antibiotics when no evidence of infection is found in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 1
The Critical Care Medicine society suggests adjusting therapy based on culture results and clinical improvement in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 2

The Intensive Care Medicine and Critical Care Medicine societies recommend avoiding delayed administration of antibiotics, as mortality increases with each hour delay in appropriate antibiotic administration in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 1, 2
The Critical Care Medicine society recommends avoiding failure to de-escalate, as continuing broad-spectrum therapy unnecessarily increases resistance risk in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 2
The Critical Care Medicine society suggests identifying and addressing infection source within 12 hours when possible to avoid overlooking source control in patients with suspected bacterial sepsis and high-grade non-Hodgkin's lymphoma 3